By inhibiting ALDH1A1 and ALDH3A1, it may be possible to overcome resistance to chemotherapy and enhance the efficacy of existing cancer treatments, providing new avenues for combating resistant cancer types. The gene discussed is ALDH1A1; the disease is cancer.